Sign In
Buy XNCR
$20.21
-1.28 (-5.96%)
At Close: Jul 31, 2026
Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?
04:35am, Thursday, 02'nd May 2024
Xencor (XNCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Xencor Appoints Bart Cornelissen as Chief Financial Officer
08:01am, Tuesday, 09'th Apr 2024
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today
Xencor, Inc. (XNCR) Q4 2023 Earnings Call Transcript
12:35am, Wednesday, 28'th Feb 2024
Xencor, Inc. (XNCR) Q4 2023 Earnings Call Transcript
Xencor (XNCR) Reports Q4 Loss, Misses Revenue Estimates
06:21pm, Tuesday, 27'th Feb 2024
Xencor (XNCR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of $0.36. This compares to loss of $0.20 per share a year ago.
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
04:01pm, Tuesday, 27'th Feb 2024
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
04:31pm, Tuesday, 20'th Feb 2024
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune dis
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?
04:41am, Monday, 19'th Feb 2024
Xencor (XNCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 Release
11:07am, Thursday, 15'th Feb 2024
Xencor (XNCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:01pm, Wednesday, 03'rd Jan 2024
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune dise
Xencor (XNCR) Soars 6.0%: Is Further Upside Left in the Stock?
11:16am, Wednesday, 03'rd Jan 2024
Xencor (XNCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
08:01am, Tuesday, 02'nd Jan 2024
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune dise
20 favorite small-cap stocks for 2024 among Wall Street analysts
12:18pm, Tuesday, 26'th Dec 2023
The 2023 stock-market rally has been led by the “Magnificent Seven” companies, which have driven an accelerating upward trend for the large-cap benchmark S&P 500. Shares of smaller and medium-size
Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference
04:01pm, Tuesday, 21'st Nov 2023
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and a
It's Small Stocks' Time To Rally — Analysts Like These 11 Best
08:00am, Tuesday, 21'st Nov 2023
It's been all about the biggest of the big S&P 500 stocks all year. But now, investors are starting to look for big gains from small stocks.
Xencor, Inc. (XNCR) Q3 2023 Earnings Call Transcript
08:29am, Wednesday, 08'th Nov 2023
Xencor, Inc. (NASDAQ:XNCR ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Charles Liles - Head, Corporate Communications and Investor Relations Bassil Dahiyat - Pre
